[Gastrointestinal tract involvement in systemic sclerosis].

Atteinte digestive de la sclérodermie systémique.
Chronic intestinal pseudo-obstruction Colonisation bactérienne chronique du grêle Ectasie vasculaire antrale gastrique Gastric antral vascular ectasia Gastroesophageal reflux disease Pseudo-obstruction intestinale chronique Reflux gastro-œsophagien Sclérodermie systémique Small intestinal bacterial overgrowth Systemic sclerosis

Journal

La Revue de medecine interne
ISSN: 1768-3122
Titre abrégé: Rev Med Interne
Pays: France
ID NLM: 8101383

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 08 09 2022
revised: 17 04 2023
accepted: 08 05 2023
medline: 23 10 2023
pubmed: 4 6 2023
entrez: 3 6 2023
Statut: ppublish

Résumé

Gastrointestinal tract involvement in systemic sclerosis concerns more than 90% of patients but is of heterogeneous clinical expression. It can involve the entire intestinal tract and be responsible for multifactorial malnutrition, which is frequent in this disease. It is a major source of deterioration in the quality of life and can even be life-threatening. Management is complex and multidisciplinary, ranging from simple hygienic and dietary measures, to specialized endoscopic or surgical interventional procedures, also including medical treatments, particularly proton pump inhibitors and prokinetics, with potential side effects. Ongoing research for new diagnostic and therapeutic tools promises to improve the management and prognosis of these patients.

Identifiants

pubmed: 37270380
pii: S0248-8663(23)00589-1
doi: 10.1016/j.revmed.2023.05.003
pii:
doi:

Substances chimiques

Proton Pump Inhibitors 0

Types de publication

English Abstract Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

410-422

Informations de copyright

Copyright © 2023 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.

Auteurs

A Renaud (A)

Service de médecine interne, Nantes université, CHU de Nantes, 1, place Alexis-Ricordeau, 44000 Nantes, France. Electronic address: arthur.renaud@chu-nantes.fr.

A Jirka (A)

Service d'hépato-gastro-entérologie, Nantes université, CHU de Nantes, 44000 Nantes, France.

C Durant (C)

Service de médecine interne, Nantes université, CHU de Nantes, 1, place Alexis-Ricordeau, 44000 Nantes, France.

J Connault (J)

Service de médecine interne, Nantes université, CHU de Nantes, 1, place Alexis-Ricordeau, 44000 Nantes, France.

O Espitia (O)

Service de médecine interne, Nantes université, CHU de Nantes, 1, place Alexis-Ricordeau, 44000 Nantes, France.

C Takoudju (C)

Service d'hépato-gastro-entérologie, Nantes université, CHU de Nantes, 44000 Nantes, France.

C Agard (C)

Service de médecine interne, Nantes université, CHU de Nantes, 1, place Alexis-Ricordeau, 44000 Nantes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH